Elise Tessier

6.6k total citations · 2 hit papers
32 papers, 3.3k citations indexed

About

Elise Tessier is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Elise Tessier has authored 32 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Health and 13 papers in Infectious Diseases. Recurrent topics in Elise Tessier's work include Vaccine Coverage and Hesitancy (16 papers), Influenza Virus Research Studies (12 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Elise Tessier is often cited by papers focused on Vaccine Coverage and Hesitancy (16 papers), Influenza Virus Research Studies (12 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Elise Tessier collaborates with scholars based in United Kingdom, Israel and United States. Elise Tessier's co-authors include Mary Ramsay, Nick Andrews, Julia Stowe, Jamie Lopez Bernal, Kevin Brown, Charlotte Gower, Ruth Simmons, Gayatri Amirthalingam, Maria Zambon and Gavin Dabrera and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Clinical Infectious Diseases.

In The Last Decade

Elise Tessier

30 papers receiving 3.2k citations

Hit Papers

Effectiveness of Covid-19 Vaccines against the B.1.617.2 ... 2021 2026 2022 2024 2021 2021 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
    2021 1.7k citations Jamie Lopez Bernal, Nick Andrews et al. New England Journal of Medicine profile →
  2. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
    2021 744 citations Jamie Lopez Bernal, Nick Andrews et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elise Tessier United Kingdom 15 2.4k 1.2k 829 503 248 32 3.3k
Gavin Dabrera United Kingdom 17 2.2k 0.9× 857 0.7× 741 0.9× 576 1.1× 270 1.1× 61 3.2k
Ruth Simmons United Kingdom 18 2.5k 1.0× 944 0.8× 749 0.9× 480 1.0× 263 1.1× 69 3.4k
Noa Dagan Israel 18 2.7k 1.1× 1.1k 0.9× 550 0.7× 325 0.6× 326 1.3× 37 4.0k
Noam Barda Israel 17 2.6k 1.1× 1.1k 0.9× 563 0.7× 302 0.6× 291 1.2× 45 3.7k
Sara E. Oliver United States 20 1.6k 0.7× 1.0k 0.9× 384 0.5× 677 1.3× 154 0.6× 54 2.9k
Bradley K. Ackerson United States 26 2.1k 0.9× 929 0.8× 396 0.5× 1.1k 2.2× 270 1.1× 100 3.4k
Sharon Alroy‐Preis Israel 12 2.0k 0.8× 943 0.8× 617 0.7× 170 0.3× 179 0.7× 26 2.4k
Julia Stowe United Kingdom 31 3.4k 1.4× 1.6k 1.3× 912 1.1× 1.3k 2.5× 360 1.5× 82 5.2k
Simon Thelwall United Kingdom 9 1.9k 0.8× 608 0.5× 581 0.7× 172 0.3× 247 1.0× 19 2.4k
Megan Wallace United States 19 1.4k 0.6× 936 0.8× 386 0.5× 343 0.7× 139 0.6× 41 2.5k

Countries citing papers authored by Elise Tessier

Since Specialization
Citations

This map shows the geographic impact of Elise Tessier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elise Tessier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elise Tessier more than expected).

Fields of papers citing papers by Elise Tessier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elise Tessier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elise Tessier. The network helps show where Elise Tessier may publish in the future.

Co-authorship network of co-authors of Elise Tessier

This figure shows the co-authorship network connecting the top 25 collaborators of Elise Tessier. A scholar is included among the top collaborators of Elise Tessier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elise Tessier. Elise Tessier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graham, Sophie, Elise Tessier, Julia Stowe, et al.. (2023). Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking. Nature Communications. 14(1). 3984–3984. 3 indexed citations
2.
Flannagan, Joe, Elise Tessier, Dimple Chudasama, et al.. (2023). Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19. Epidemiology and Infection. 151. e51–e51.
3.
Shaw, Rebecca, Andrew J. Doyle, Julia Stowe, et al.. (2023). Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria. Vaccine. 41(36). 5330–5337.
4.
Tessier, Elise, Sophie Nash, Anna Mensah, et al.. (2023). Pertussis immunisation strategies to optimise infant pertussis control: A narrative systematic review. Vaccine. 41(41). 5957–5964. 8 indexed citations
5.
6.
Mulholland, Rachel, Utkarsh Agrawal, Helen Bedford, et al.. (2022). Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data. PLoS Medicine. 19(2). e1003916–e1003916. 21 indexed citations
7.
Amirthalingam, Gayatri, Helen Campbell, Sonia Ribeiro, et al.. (2022). Optimization of Timing of Maternal Pertussis Immunization From 6 Years of Postimplementation Surveillance Data in England. Clinical Infectious Diseases. 76(3). e1129–e1139. 20 indexed citations
8.
Tessier, Elise, Helen Campbell, Sonia Ribeiro, et al.. (2022). Impact of the COVID-19 pandemic on Bordetella pertussis infections in England. BMC Public Health. 22(1). 405–405. 46 indexed citations
9.
Tessier, Elise, Anissa Lakhani, Michael Edelstein, et al.. (2022). Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study. BMJ Open. 12(3). e055278–e055278. 15 indexed citations
10.
Sinnathamby, Mary, Fiona Warburton, Nick Andrews, et al.. (2021). Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017. Influenza and Other Respiratory Viruses. 16(1). 113–124. 6 indexed citations
11.
Stowe, Julia, Elise Tessier, Hongxin Zhao, et al.. (2021). Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. International Journal of Epidemiology. 50(4). 1124–1133. 154 indexed citations
12.
Sandmann, Frank, Mark Jit, Nick Andrews, et al.. (2021). Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis. Vaccine. 39(32). 4500–4509. 5 indexed citations
13.
Amirthalingam, Gayatri, Jamie Lopez Bernal, Nick Andrews, et al.. (2021). Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England. Nature Communications. 12(1). 7217–7217. 66 indexed citations
14.
Bernal, Jamie Lopez, Nick Andrews, Charlotte Gower, et al.. (2021). Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. New England Journal of Medicine. 385(7). 585–594. 1738 indexed citations breakdown →
15.
Vusirikala, Amoolya, Heather Whitaker, Samuel E. I. Jones, et al.. (2021). Seroprevalence of SARS-CoV-2 Antibodies in University Students: Cross-sectional Study, December 2020, England. SSRN Electronic Journal. 4 indexed citations
16.
Bernal, Jamie Lopez, Nick Andrews, Charlotte Gower, et al.. (2021). Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 373. n1088–n1088. 744 indexed citations breakdown →
17.
Tessier, Elise, Joanne White, Nick Andrews, et al.. (2020). School-based vaccination programmes: An evaluation of school immunisation delivery models in England in 2015/16. Vaccine. 38(15). 3149–3156. 4 indexed citations
18.
White, Joanne, et al.. (2019). What school-level and area-level factors influenced HPV and MenACWY vaccine coverage in England in 2016/2017? An ecological study. BMJ Open. 9(7). e029087–e029087. 13 indexed citations
19.
Collantes, Carmen de Lucas, et al.. (2019). Nutritional status of iodine in children: When appropriateness relies on milk consumption and not adequate coverage of iodized salt in households. Clinical Nutrition ESPEN. 30. 52–58. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gavin Dabrera Breakdown of academic impact, for papers by Ruth Simmons Breakdown of academic impact, for papers by Noa Dagan Breakdown of academic impact, for papers by Noam Barda Breakdown of academic impact, for papers by Sara E. Oliver Breakdown of academic impact, for papers by Bradley K. Ackerson Breakdown of academic impact, for papers by Sharon Alroy‐Preis Breakdown of academic impact, for papers by Julia Stowe Breakdown of academic impact, for papers by Simon Thelwall Breakdown of academic impact, for papers by Megan Wallace
Rankless by CCL
2026